Ear :: Viral protein is an effective preventative against infection
Using lysins, a protein from viruses that infect bacteria, scientists have developed a novel way to prevent kids from developing middle ear infections.
Using lysins, a protein from viruses that infect bacteria, scientists have developed a novel way to prevent kids from developing middle ear infections.
Sutent (sunitinib malate) has received a European Association of Urology recommendation, as first-line therapy in patients with metastatic renal cell carcinoma of good and intermediate risk, just two months after gaining EU marketing authorization for first line use in all patients with advanced and/or metastatic renal cell carcinoma.
In a remote area of the Amazon, globalization is threatening the time-honored transmission of plant knowledge from generation to generation, with adverse effects on childhood health and nutrition. In a novel study published online this week in the Proceedings of the National Academy of Sciences, researchers report that parents, and especially mothers, who know more about plants and how to use them, have healthier children, independent of other factors such as education, market participation or acculturation.
Many Australian adults are enjoying improved oral health, but some are still missing out, according to a report by the Australian Institute of Health and Welfare (AIHW) launched by the Hon Tony Abbott at the 32nd Australian Dental Congress in Sydney.
Deputy Prime Minister and Leader of the Nationals Mark Vaile has endorsed a national campaign developed by the Rural Doctors Association and beyondblue to encourage more rural Australians to seek help from their local GP for mental and physical health problems.
Eli Lilly and Company announced plans to invest an additional $50 million in an innovative, global partnership to fight Multi-Drug Resistant Tuberculosis (MDR-TB). The announcement is being made in conjunction with World TB Day activities.
The UK Government is launching two consultations that aim to make it easier for patients to get the medicines they need by allowing:-
Sanofi-aventis announced that Acomplia? 20mg (rimonabant), the first drug in a new therapeutic class, the selective cannabinoid-1 receptor antagonists, has now been included in the list of pharmaceutical products reimbursable by the Social Security, by virtue of a decree dated March 22, 2007, published in the Official Journal of the French Republic.
Many young and middle-aged people of Chinese ancestry told they are at risk of going blind from glaucoma may be getting incorrect information, say researchers at the Stanford University School of Medicine.
Today, during the 85th General Session of the International Association for Dental Research, Forsyth Institute scientists are reporting that they have developed an effective program for eliminating cavities.